Scientist/Senior Scientist for Pharmacology jobs in United States
cer-icon
Apply on Employer Site
company-logo

Biocytogen · 3 weeks ago

Scientist/Senior Scientist for Pharmacology

Biocytogen Boston Corp is seeking a highly motivated and versatile Pharmacology Scientist to support both in vivo and in vitro preclinical research services in the fields of immunology, immuno-oncology, metabolic disease and neurology. The successful candidate will engage in hands-on experimental work and strategic project management to support biotech and pharmaceutical partners.

BiotechnologyHealth CareMedical DeviceTherapeutics
check
H1B Sponsor Likelynote

Responsibilities

Design and develop animal models, execute in vivo experiments to evaluate the biological efficacy of novel therapeutic agents
Independently lead in vivo service projects and preclinical studies, acting as Project Manager or Study Director
Perform animal handling, tumor inoculation, drug administration via multiple routes, blood and tissue collection, tumor measurements, and PK/PD studies
Design and execute internal model-building projects and characterize various humanized mouse models
Provide troubleshooting support and technical guidance to junior associates
Collaborate closely with the BD/Sales team for client project planning and technical discussions
Present project results to clients and internal stakeholders; prepare scientific reports and summaries
Mentor and facilitate the growth of junior research associates
Independently develop, validate, and perform a broad range of in vitro and ex vivo assays including: Immune cell profiling from blood and tissues
Functional assays using primary cells (T cells, NK cells, macrophages)
Cytokine profiling, cytotoxicity, and apoptosis assays
Develop new assay technologies by researching scientific literature and adapting methodologies from collaborations and other internal teams
Perform flow cytometry (FACS), ELISA, Western blot, qRT-PCR, and multiplex cytokine analyses
Contribute to the design and support of in vivo pharmacology studies from an in vitro perspective
Present research findings at internal meetings and contribute to external scientific discussions

Qualification

PhD in pharmacologyVivo pharmacologyCell-based immunological assaysFlow cytometryPK/PD model analysisSurgical procedures in rodentsCommunication skillsOrganizational skillsTeam collaboration skills

Required

PhD in pharmacology, immunology, cancer biology, or related biomedical field
Extensive hands-on experience in animal models and preclinical in vivo pharmacology
Proven skills in cell-based immunological assays including T cell activation, NK cell-mediated cytotoxicity, and macrophage functional assays
Proficiency in PK/PD model establishment and analysis
Expertise in flow cytometry, cytokine profiling (ELISA, qRT-PCR, multiplex assays), and immune cell isolation from tissues
Experience with surgical procedures in rodents is highly desirable
Cross-functional knowledge across therapeutic areas is a plus
Strong communication, organizational, and team collaboration skills with the ability to prioritize in a fast-paced environment
Demonstrated ability to independently manage projects and work with cross-functional teams

Benefits

Medical Insurance
Dental Insurance
Vision Insurance
Health Reimbursement Accounts
Life and AD&D Insurance
Short & Long Term Disability Insurance
401K with Company Match
Paid Time Off
Paid Sick Days & Holidays

Company

Biocytogen

twittertwittertwitter
company-logo
Biocytogen is a biopharmaceutical company that provides integrated solutions for antibody drug development.

H1B Sponsorship

Biocytogen has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (10)
2024 (11)
2023 (3)
2022 (4)
2021 (2)
2020 (4)

Funding

Current Stage
Public Company
Total Funding
$335.15M
Key Investors
CMB International Capital Corporation
2022-09-01IPO
2022-08-19Post Ipo Equity· $49.8M
2021-06-22Series E

Leadership Team

leader-logo
Qingcong Lin
CEO of Biocytogen Boston Corp
linkedin
Company data provided by crunchbase